Quantum BioPharma Q2 EPS $(3.23) Compared With $(0.08) YoY

Quantum BioPharma (NASDAQ: QNTM) reported quarterly losses of $(3.23) per share which missed the analyst consensus estimate of $(0.07) by 4514.29 percent. This is a 3937.5 percent decrease over losses of $(0.08) per share from the same period last year.